- Home
- WH vs RVMD Comparison
WH vs RVMD Comparison
Compare WH & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WH
- RVMD
- Stock Information
- Founded
- WH 2017
- RVMD 2014
- Country
- WH United States
- RVMD United States
- Employees
- WH N/A
- RVMD N/A
- Industry
- WH Hotels/Resorts
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WH Consumer Discretionary
- RVMD Health Care
- Exchange
- WH Nasdaq
- RVMD Nasdaq
- Market Cap
- WH 6.5B
- RVMD 7.4B
- IPO Year
- WH N/A
- RVMD 2020
- Fundamental
- Price
- WH $79.34
- RVMD $39.66
- Analyst Decision
- WH Strong Buy
- RVMD Strong Buy
- Analyst Count
- WH 11
- RVMD 12
- Target Price
- WH $108.07
- RVMD $68.67
- AVG Volume (30 Days)
- WH 967.1K
- RVMD 1.7M
- Earning Date
- WH 07-23-2025
- RVMD 08-06-2025
- Dividend Yield
- WH 2.08%
- RVMD N/A
- EPS Growth
- WH 48.31
- RVMD N/A
- EPS
- WH 4.22
- RVMD N/A
- Revenue
- WH $1,416,000,000.00
- RVMD N/A
- Revenue This Year
- WH $7.69
- RVMD N/A
- Revenue Next Year
- WH $6.55
- RVMD $241.39
- P/E Ratio
- WH $18.64
- RVMD N/A
- Revenue Growth
- WH 2.61
- RVMD N/A
- 52 Week Low
- WH $70.08
- RVMD $29.17
- 52 Week High
- WH $113.07
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- WH 38.17
- RVMD 49.08
- Support Level
- WH $78.82
- RVMD $38.57
- Resistance Level
- WH $81.83
- RVMD $42.40
- Average True Range (ATR)
- WH 1.82
- RVMD 1.38
- MACD
- WH -0.31
- RVMD -0.16
- Stochastic Oscillator
- WH 11.67
- RVMD 28.46
About WH Wyndham Hotels & Resorts Inc.
As of Dec. 31, 2024, Wyndham Hotels & Resorts operates 903,000 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.